Cargando…
Chronic kidney disease and the outcomes of fibrinolysis for ST-segment elevation myocardial infarction: A real-world study
BACKGROUND: In low-resource regions, fibrinolytic therapy is often the only option for ST-elevation myocardial infarction (STEMI) patients as primary percutaneous coronary intervention (PCI) is often not available and patients are hardly transferred to a medical center with PCI capacity within the f...
Autores principales: | Xie, Wuxiang, Patel, Anushka, Boersma, Eric, Feng, Lin, Li, Min, Gao, Runlin, Wu, Yangfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815111/ https://www.ncbi.nlm.nih.gov/pubmed/33465135 http://dx.doi.org/10.1371/journal.pone.0245576 |
Ejemplares similares
-
Fibrinolysis vs. primary percutaneous coronary intervention for ST‐segment elevation myocardial infarction cardiogenic shock
por: Vallabhajosyula, Saraschandra, et al.
Publicado: (2021) -
Recent Trends in Hospitalization for Acute Myocardial Infarction in Beijing: Increasing Overall Burden and a Transition From ST-Segment Elevation to Non-ST-Segment Elevation Myocardial Infarction in a Population-Based Study
por: Zhang, Qian, et al.
Publicado: (2016) -
Percutaneous Coronary Intervention after Fibrinolysis for ST-Segment Elevation Myocardial Infarction Patients: An Updated Systematic Review and Meta-Analysis
por: Liu, Feng, et al.
Publicado: (2015) -
The Comparison of the Outcomes between Primary PCI, Fibrinolysis, and No Reperfusion in Patients ≥ 75 Years Old with ST-Segment Elevation Myocardial Infarction: Results from the Chinese Acute Myocardial Infarction (CAMI) Registry
por: Peiyuan, He, et al.
Publicado: (2016) -
A fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era
por: Jamal, Javeria, et al.
Publicado: (2021)